title: Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning.
abstract: Potent organophosphorous (OP) agents, such as VX, are hazardous by absorption through the skin and are resistant to conventional pharmacological antidotal treatments. The residence time of a stoichiometric bioscavenger, human butyrylcholinesterase (huBuChE), in the plasma more closely matches that of VX than do the residence times of conventional therapy drugs (oxime, anti-muscarinic, anticonvulsant). Intramuscular (i.m.) huBuChE afforded almost complete protection when administered prior to the onset of observable cholinergic signs of VX poisoning, but once signs of poisoning became evident the efficacy of i.m. huBuChE decreased. A combination of nerve agent therapy drugs (oxime, anti-muscarinic, anticonvulsant) with huBuChE (i.m.) protected 100% (8/8) of guinea-pigs from a lethal dose of VX (0.74 mg/kg) to 48 h, even when administered on signs of poisoning. Survival was presumed to be due to immediate alleviation of the cholinergic crisis by the conventional pharmacological treatment drugs, in conjunction with bioscavenger that prevented further absorbed agent reaching the AChE targets. Evidence to support this proposed mechanism of action was obtained from PKPD experiments in which multiple blood samples and microdialysate samples were collected from individual conscious ambulatory animals. Plasma concentrations of intramuscularly-administered atropine, diazepam and HI-6 reached a peak within 15 min and were eliminated rapidly within 4h. Plasma concentrations of huBuChE administered by the i.m. route took approximately 24h to reach a peak, but were well-maintained over the subsequent 7days. Thus, the pharmacological therapy rapidly treated the initial signs of poisoning, whilst the bioscavenger provided prolonged protection by neutralising further nerve agent entering the bloodstream and preventing it from reaching the target organs.
authors.affiliation: Biomedical Sciences Department, Dstl Porton Down, Salisbury, Wiltshire SP4 0JQ, United Kingdom. hmumford@dstl.gov.uk
authors.forename: Helen
authors.initials: H
authors.lastname: Mumford
authors.forename: Cerys J
authors.initials: CJ
authors.lastname: Docx
authors.forename: Matthew E
authors.initials: ME
authors.lastname: Price
authors.forename: A Christopher
authors.initials: AC
authors.lastname: Green
authors.forename: John E H
authors.initials: JE
authors.lastname: Tattersall
authors.forename: Stuart J
authors.initials: SJ
authors.lastname: Armstrong
mesh_terms: D000110:Acetylcholinesterase / Q000097:blood; D000818:Animals; D000931:Antidotes / Q000008:administration & dosage; D001285:Atropine / Q000008:administration & dosage; D002091:Butyrylcholinesterase / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use*; D002619:Chemical Warfare Agents / Q000506:poisoning*; D002801:Cholinesterase Reactivators / Q000008:administration & dosage; D003975:Diazepam / Q000008:administration & dosage; D006168:Guinea Pigs; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D062025:Organophosphate Poisoning / Q000097:blood / Q000628:therapy*; D009946:Organothiophosphorus Compounds / Q000506:poisoning; D010091:Oximes / Q000008:administration & dosage; D011726:Pyridinium Compounds / Q000008:administration & dosage
chemical_list: D000110:Acetylcholinesterase; D000931:Antidotes; D001285:Atropine; D002091:Butyrylcholinesterase; D002619:Chemical Warfare Agents; D002801:Cholinesterase Reactivators; D003975:Diazepam; D009946:Organothiophosphorus Compounds; D010091:Oximes; D011726:Pyridinium Compounds; C009680:VX-agent; C022870:asoxime chloride